Tokyo exchange. Sector: Healthcare. Industry: Medical Instruments & Supplies. Location Japan, Tokyo.

HOYA Corporation [7741.TJapan

14,925USD100 (-0.67%)

• At close Fri Oct 07 2022

36,920,387,031 USD
MARKET CAP
42.446
PE
.
BETA (5y)
335.250
EPS

profit

203%

for 5 years

profit

137%

for 3 years

profit

41%

for 2 years

profit

11%

for 1 year

profit

1%

for this year

About HOYA Corporation

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

HOYA株式会社の公式サイト。情報・通信、アイケア、医療関連の製品、企業情報、投資家情報、CSR情報などを掲載しています。

HOYA Corporation
https://www.hoya.com
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.